Featured Stories
China Bans Meta’s Acquisition of Manus on National Security Grounds
Beijing blocks Meta's $2.5B Manus acquisition over national security. Uncover why this unwound deal signals a major shift in global tech M&A landscape.
Powell's Fed Future: Chairmanship Ends, But Will He Stay as Governor?
Jerome Powell's decision on his Fed governor seat will define the central bank's next era. Understand its impact on Biden's Fed appointments & policy.
The $50 Movie Ticket Has Arrived: Theaters Bet Big on Premium Pricing, Riling Hollywood
The $50 movie ticket is a reality. Explore how premium cinema pricing impacts theaters, studios, and your moviegoing experience. Is cinema now a luxury?
Tracking Corporate Layoffs in 2026
While Q1 2026 shows overall job stability, the tech sector faces a 40% surge in AI-driven layoffs. Discover AI's profound impact on modern jobs.
Oil Pushes Higher as Stalled Peace Talks Weigh on Sentiment
Stalled U.S.-Iran talks send global oil prices surging and equity markets lower. Get insights into the renewed geopolitical premium and tight supply outlook.
Stock Market Today: Oil Climbs After Peace Talks Stall
Markets open lower as crude oil jumps past $105 after peace talks stall. S&P 500, Nasdaq slip. See how inflation & earnings season impact your portfolio.
Galp's Key Earnings Metric Soars on Production Surge and Favorable Pricing
Galp's Q1 adjusted net profit soared 41% to €272M, fueled by strategic efficiency, higher production, & strong commodity prices. Get the full analysis.
Oil Above $100 Signals Supply Stress
Brent crude oil surges past $100. Geopolitical instability, thin supply & demand resilience make this the new floor, fueling global inflation & costs.
China’s Industrial Profits Jump Despite Tighter Energy Markets
China's industrial profits jumped 15.8% in March, defying soaring global energy costs. Learn how domestic demand & gov't support fueled this surprising resilience.
Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal
Sun Pharma acquires Organon for $11.75B, targeting top 3 global women's health leadership. See how this blockbuster deal transforms pharma.
Opinion & Analysis
Elon Musk Is an Underdog in His $180 Billion Fight Against OpenAI
Elon Musk's lawsuit against OpenAI challenges its core mission, seeking to claw back billions. Explore this complex fight for AI's soul and governance.
Budget Airlines Pitch Trump Administration on $2.5 Billion Relief Plan
Spirit Airlines & budget carriers lobby the Trump Administration for a $2.5B relief package, seeking grants and tax breaks to avert layoffs.
Sun Pharmaceutical to Acquire Organon in Landmark $11.75 Billion All-Cash Deal
India's Sun Pharma to acquire Organon for $11.75 billion in cash, expanding its global footprint in women's health and biosimilars. Get details.
Corporate America Is Minting Money—and Not Just in Tech and Finance
US corporations defy economic headwinds, posting record profits across diverse sectors. Explore how pricing power & efficiency drive this surprising boom.
Oil Rises Amid Rising Strait of Hormuz Tensions
Strait of Hormuz tensions push oil prices higher (Brent $85.20). Asian equities advance, showing resilience despite energy market risk. Get the full analysis.
The Pentagon Needed Rare Earths—and Found a Supplier in Malaysia
Facing China's rare earth monopoly, the US DoD secures a deal with Malaysia, diversifying critical mineral supply chains for defense and tech.